Geroscience in the Age of COVID-19
- PMID: 32765937
- PMCID: PMC7390533
- DOI: 10.14336/AD.2020.0629
Geroscience in the Age of COVID-19
Abstract
The data on COVID-19 is clear on at least one point: Older adults are most vulnerable to hospitalization, disability and death following infection with the novel coronavirus. Therefore, therapeutically addressing degenerative aging processes as the main risk factors appears promising for tackling the present crisis and is expected to be relevant when tackling future infections, epidemics and pandemics. Therefore, utilizing a geroscience approach, targeting aging processes to prevent multimorbidity, via initiating broad clinical trials of potential geroprotective therapies, is recommended.
Keywords: COVID-19; aging biomarkers; geroprotectors; geroscience; immunosenescence.
Copyright: © 2020 Barzilai et al.
References
-
- Wu Z, McGoogan JM (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 323(13):1239-1242. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources